Host–Microbial Interactions in Idiopathic Pulmonary Fibrosis
Open Access
- 15 June 2017
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 195 (12), 1640-1650
- https://doi.org/10.1164/rccm.201607-1408oc
Abstract
Rationale: Changes in the respiratory microbiome are associated with disease progression in idiopathic pulmonary fibrosis (IPF). The role of the host response to the respiratory microbiome remains unknown. Objectives: To explore the host–microbial interactions in IPF. Methods: Sixty patients diagnosed with IPF were prospectively enrolled together with 20 matched control subjects. Subjects underwent bronchoalveolar lavage (BAL), and peripheral whole blood was collected into PAXgene tubes for all subjects at baseline. For subjects with IPF, additional samples were taken at 1, 3, and 6 months and (if alive) 1 year. Gene expression profiles were generated using Affymetrix Human Gene 1.1 ST arrays. Measurements and Main Results: By network analysis of gene expression data, we identified two gene modules that strongly associated with a diagnosis of IPF, BAL bacterial burden (determined by 16S quantitative polymerase chain reaction), and specific microbial operational taxonomic units, as well as with lavage and peripheral blood neutrophilia. Genes within these modules that are involved in the host defense response include NLRC4, PGLYRP1, MMP9, and DEFA4. The modules also contain two genes encoding specific antimicrobial peptides (SLPI and CAMP). Many of these particular transcripts were associated with survival and showed longitudinal overexpression in subjects experiencing disease progression, further strengthening the relationship of the transcripts with disease. Conclusions: Integrated analysis of the host transcriptome and microbial signatures demonstrated an apparent host response to the presence of an altered or more abundant microbiome. These responses remained elevated in longitudinal follow-up, suggesting that the bacterial communities of the lower airways may act as persistent stimuli for repetitive alveolar injury in IPF.This publication has 37 references indexed in Scilit:
- Matrix Metalloproteinases as Therapeutic Targets for Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory Cell and Molecular Biology, 2015
- Muc5b is required for airway defenceNature, 2013
- Curcumin nanoformulations: a future nanomedicine for cancerDrug Discovery Today, 2012
- Strategies for aggregating gene expression data: The collapseRows R functionBMC Bioinformatics, 2011
- A Variant in the Promoter ofMUC5Band Idiopathic Pulmonary FibrosisThe New England Journal of Medicine, 2011
- Eigengene networks for studying the relationships between co-expression modulesBMC Systems Biology, 2007
- Human peptidoglycan recognition protein S is an effector of neutrophil-mediated innate immunityBlood, 2005
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- Taurine and niacin block lung injury and fibrosis by down-regulating bleomycin-induced activation of transcription nuclear factor-kappaB in mice.2000
- Phosphorylation Meets Ubiquitination: The Control of NF-κB ActivityAnnual Review of Immunology, 2000